Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Vandervoort

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Neurology|January 1, 1989
The prevalence of primary Sjögren's syndrome in a multiple sclerosis populationJ H Noseworthy, B H Bass, M K Vandervoort, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2015
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trialsV Jairath, R Khanna, G Y Zou, et al.
Annals of Neurology|November 1, 1992
Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosisS Wiebe, D H Lee, S J Karlik, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activityR Khanna, G Zou, G D'Haens, et al.
Neurology|July 1, 1993
An open-trial evaluation of mitoxantrone in the treatment of progressive MSJ H Noseworthy, M B Hopkins, M K Vandervoort, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2017
The development of a magnetic resonance imaging index for fistulising Crohn's diseaseM A Samaan, C A J Puylaert, B G Levesque, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2017
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitisG R D'Haens, W J Sandborn, G Zou, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Neurology|January 1, 1989
The prevalence of primary Sjögren's syndrome in a multiple sclerosis populationJ H Noseworthy, B H Bass, M K Vandervoort, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2015
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trialsV Jairath, R Khanna, G Y Zou, et al.
Annals of Neurology|November 1, 1992
Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosisS Wiebe, D H Lee, S J Karlik, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activityR Khanna, G Zou, G D'Haens, et al.
Neurology|July 1, 1993
An open-trial evaluation of mitoxantrone in the treatment of progressive MSJ H Noseworthy, M B Hopkins, M K Vandervoort, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2017
The development of a magnetic resonance imaging index for fistulising Crohn's diseaseM A Samaan, C A J Puylaert, B G Levesque, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2017
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitisG R D'Haens, W J Sandborn, G Zou, et al.
Pageof 2